PEF therapy for advanced esophageal cancer
Part of Cancer, Digestive system clinical trials.
This trial tests a new treatment called pulsed electric field (PEF) therapy for people with advanced or unresectable esophageal squamous cell carcinoma. PEF uses short electrical pulses to target and destroy cancer cells. This study is for patients who cannot have surgery or standard treatments, and looks at how safe and effective this therapy is.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 20 years or older.
- You need to be in fairly good daily health (ECOG score of 0 or 1), meaning you can take care of yourself and are up and about.
- Your blood counts must be within certain ranges, including enough white blood cells, platelets, and hemoglobin.
- If you are a woman who could become pregnant, you must have a negative pregnancy test and agree to use birth control.
- You cannot have active infections, severe esophageal blockage, or have had a stent placed in your esophagus.
- You must not have other active cancers or certain medical conditions like brain metastases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a personalized approach to palliative care for people with advanced or recurrent esophageal cancer who are being treated with immunotherapy. It aims to improve quality of life and symptom management.
This study looks at whether detailed scans taken before treatment can predict how well chemo and immunotherapy will work for advanced esophageal cancer. The goal is to improve treatment planning and potentially reduce side effects by personalizing care.
This trial tests a new treatment that uses short electrical pulses (pulsed electric field ablation) to destroy small lung tumors. It may be an option for people with limited, early-stage non-small cell lung cancer who can tolerate a minimally invasive procedure.
This trial studies whether adding an anti-PD-1 immunotherapy (with chemotherapy) together with radiation can help people with advanced esophageal squamous cell cancer. It’s for cases where surgery or standard definitive chemoradiation can’t be done, or the cancer has spread to distant sites.
This trial tests a new treatment plan for people with advanced esophageal squamous cell carcinoma that has spread to lymph nodes but not to other organs. It aims to find the best way to treat this cancer using radiation and other therapies.
This trial tests a new treatment called pulsed electric field therapy for people with advanced lung cancer (stage III or IV) that has not responded to first-line immunotherapy. It uses targeted electrical pulses to destroy tumor cells, and may be an option for those who still have other measurable tumors.
Hear when a new Esophageal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.